Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin.

Lane RS, Femel J, Breazeale AP, Loo CP, Thibault G, Kaempf A, Mori M, Tsujikawa T, Chang YH, Lund AW.

J Exp Med. 2018 Oct 31. pii: jem.20180654. doi: 10.1084/jem.20180654. [Epub ahead of print]

PMID:
30381467
2.

Toward Minimal Residual Disease-Directed Therapy in Melanoma.

Rambow F, Rogiers A, Marin-Bejar O, Aibar S, Femel J, Dewaele M, Karras P, Brown D, Chang YH, Debiec-Rychter M, Adriaens C, Radaelli E, Wolter P, Bechter O, Dummer R, Levesque M, Piris A, Frederick DT, Boland G, Flaherty KT, van den Oord J, Voet T, Aerts S, Lund AW, Marine JC.

Cell. 2018 Aug 9;174(4):843-855.e19. doi: 10.1016/j.cell.2018.06.025. Epub 2018 Jul 12.

PMID:
30017245
3.

Development of a novel therapeutic vaccine carrier that sustains high antibody titers against several targets simultaneously.

Saupe F, Reichel M, Huijbers EJ, Femel J, Markgren PO, Andersson CE, Deindl S, Danielson UH, Hellman LT, Olsson AK.

FASEB J. 2017 Mar;31(3):1204-1214. doi: 10.1096/fj.201600820R. Epub 2016 Dec 19.

PMID:
27993994
4.

Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma.

Roy A, Femel J, Huijbers EJ, Spillmann D, Larsson E, Ringvall M, Olsson AK, Åbrink M.

PLoS One. 2016 May 25;11(5):e0156151. doi: 10.1371/journal.pone.0156151. eCollection 2016.

5.

Neutrophil Extracellular Traps Accumulate in Peripheral Blood Vessels and Compromise Organ Function in Tumor-Bearing Animals.

Cedervall J, Zhang Y, Huang H, Zhang L, Femel J, Dimberg A, Olsson AK.

Cancer Res. 2015 Jul 1;75(13):2653-62. doi: 10.1158/0008-5472.CAN-14-3299. Epub 2015 Jun 12.

6.

Vaccines targeting self-antigens: mechanisms and efficacy-determining parameters.

Saupe F, Huijbers EJ, Hein T, Femel J, Cedervall J, Olsson AK, Hellman L.

FASEB J. 2015 Aug;29(8):3253-62. doi: 10.1096/fj.15-271502. Epub 2015 Apr 13.

PMID:
25868727
7.

Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer.

Femel J, Huijbers EJ, Saupe F, Cedervall J, Zhang L, Roswall P, Larsson E, Olofsson H, Pietras K, Dimberg A, Hellman L, Olsson AK.

Oncotarget. 2014 Dec 15;5(23):12418-27.

8.

The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B--a prerequisite for clinical development.

Huijbers EJ, Femel J, Andersson K, Björkelund H, Hellman L, Olsson AK.

Vaccine. 2012 Jan 5;30(2):225-30. doi: 10.1016/j.vaccine.2011.11.010. Epub 2011 Nov 10.

PMID:
22079080
9.

Vaccination against the extra domain-B of fibronectin as a novel tumor therapy.

Huijbers EJ, Ringvall M, Femel J, Kalamajski S, Lukinius A, Abrink M, Hellman L, Olsson AK.

FASEB J. 2010 Nov;24(11):4535-44. doi: 10.1096/fj.10-163022. Epub 2010 Jul 15.

PMID:
20634349

Supplemental Content

Support Center